Nueterra Capital

Three partners lead the firm: Dan Tasset, Jeremy Tasset, and George Lester. Dan Tasset founded the predecessor operating company that built and managed over 150 surgery centers. The Tassets and Lester collectively shape investment decisions, drawing on the operational expertise of a 10-person dedicated team and a network of healthcare facility executives.

The firm leverages its owned and managed healthcare facilities as a live testing environment. Early-stage companies can pilot their technology within these operating sites, which generates real-world validation data and creates a sourcing funnel of founders seeking operational feedback — a circuit that reduces diligence risk and surfaces deals outside the coastal venture hubs.

It operates as a private equity and venture capital firm built atop a family office foundation. The website explicitly frames its approach as 'Cutting-Edge Approach from a Family Office,' and the entity draws on the capital and operating infrastructure of the Tasset family’s broader healthcare holdings, including real estate and surgery center businesses.

Alongside direct equity, the firm commits to external venture funds. Its portfolio includes stakes in Firebrand Ventures, Iron Prairie Ventures, and Open Prairie Ventures, indicating a hybrid model that blends direct company investing with LP positions in emerging-manager and regional venture funds.

The portfolio shows no exposure to non-healthcare enterprise software, deep tech, consumer platforms, or hard sciences outside medical applications. The firm’s tagline — 'empowering the next generation of startups' — is filtered almost exclusively through the lens of healthcare and adjacent technology, with no disclosed activity in fintech, logistics, or manufacturing.

Both entities appear in the Nueterra portfolio as operating companies. NueHealth is the firm's surgery-center platform, and Monument Healthcare Properties held real estate assets that were sold to Grayson Capital — one of Nueterra’s co-investment relationships. These entities form the operational chassis that supplies the firm’s clinical pilot network.

The firm co-invested alongside Linden Capital Partners in IVX Health and has a track record of transacting with regional private equity sponsors, such as the sale of Casetabs to HST Pathways and the divestiture of PT Partners to Peak Sport & Spine. This pattern suggests openness to syndicating with sponsors on both buyouts and exits.